Abstract. In the production of cattle nuclear transfer embryos, the production efficiency is affected by the oocyte developmental competence and successful enucleation rate. This study investigated the effect of treating oocytes with milrinone, a phosphodiesterase inhibitor, on these two characteristics. When cumulus-oocyte complexes (COCs) were cultured for 19 h with 0, 50 or 100 μM of milrinone, the enucleation rate was significantly improved by 100 μM milrinone. However, milrinone treatment during in vitro maturation (IVM) also delayed meiotic progression by at least 2 h, which would affect the examination of enucleation rate and developmental competence of oocytes. Thus, in the second experiment, meiotic resumption was temporarily inhibited with butyrolactone I (BL-I; 100 μM, 18 h) to decrease the delayed maturation caused by milrinone; this enabled a more accurate comparison of the effects of milrinone after oocyte maturation. In nuclear transfer embryo production, oocytes treated with milrinone (100 μM, 20 h) showed a significantly higher rate of enucleation compared with that of control oocytes. This improved enucleation rate was associated with a closer location of the metaphase plate to the first polar body in the treated oocytes compared with that in control oocytes. Furthermore, milrinone improved the frequency of development to the blastocyst stage in the resulting embryos. In conclusion, milrinone supplementation during IVM improved enucleation rates by rendering the metaphase plate in close proximity to the first polar body, and this treatment also improved oocyte developmental competence. These benefits additively improved the yield of cloned embryos that developed to the blastocyst stage. Key words: Bovine oocyte, Development, Enucleation, Milrinone, Nuclear transfer embryo (J. Reprod. Dev. 58: [476][477][478][479][480][481][482][483] 2012) W hile mammalian cloning technology requires high quality oocytes (preferably, ovulated ones) for the preparation of recipient cytoplasm, the requirements for cattle cloning technology are relatively lenient with regard to the use of cytoplasm prepared from in vitro-matured oocytes [1] . The latter technology is advantageous for nuclear transfer embryo production since a major rate-limiting process is the preparation of the recipient cytoplasm, and the collection of in vitro-matured oocytes is relatively easier than that of ovulated oocytes. Further technical sophistication of oocyte culture conditions will have significant effects on nuclear transfer embryo production in cattle. In particular, two characteristics regarding oocyte culture can facilitate the efficiency of nuclear transfer embryo production-the enhancement of oocyte quality by manipulating culture conditions and the improvement of the rate of successful enucleation, which is a crucial step in the preparation of recipient cytoplasm by removing the chromosomes.
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As for the developmental competence of bovine oocytes, the effects of elevated cyclic adenosine monophosphate (cAMP) levels have been extensively studied [2] [3] [4] . For example, Thomas et al. [4] reported that supplementation of the culture medium with milrinone-a phosphodiesterase inhibitor-during oocyte maturation improved the development of the resultant embryos after in vitro fertilization. In contrast, optimizing the enucleation rate of bovine oocytes has required extensive efforts from various aspects [5] [6] [7] [8] [9] [10] . Various improvements were required because of the difficulty in locating the chromosomes/metaphase plate through the lipid-rich cytoplasm of the bovine oocytes. Unless a specially equipped microscope is used to visualize the metaphase spindle [11] , we cannot determine whether the cytoplasmic portion contains chromosomes at the time of its removal [8] . Although it is possible to visualize chromosomes stained with Hoechst under UV illumination during the enucleation procedure, a concern about possible negative effects is inevitable. Usually, the first polar body is used as a marker to estimate the location of the chromosomes/metaphase plate. The efficiency of mechanical enucleation is 60-80% in cattle [7, 12] and 70-90% in pigs [13, 14] . Thus, further improvements are desired for efficient mechanical enucleation of oocytes in cattle.
Recently, it has been reported that the exposure of miniature porcine oocytes during in vitro maturation to dibutyryl cyclic adenosine monophosphate (dbcAMP)-a cell-permeable cAMP analog-im-proved the efficiency of mechanical enucleation [15] . This finding suggests that improved oocyte competence and enucleation efficiency could be achieved in cattle by a single treatment that elevates cAMP levels. In the present study, the effects of milrinone treatment during in vitro bovine oocyte maturation on the enucleation rate and the subsequent developmental capacity of nuclear transferred embryos were examined.
Materials and Methods

Collection of cumulus-oocyte complexes (COCs)
Bovine ovaries were obtained from a local abattoir and transported to the laboratory in calcium-and magnesium-free Dulbecco's phosphatebuffered saline (PBS). COCs were obtained with a syringe and needle from follicles measuring 2-6 mm in diameter. The collected COCs were rinsed twice in a HEPES-buffered Tyrode's solution containing 0.1% polyvinyl alcohol (Sigma-Aldrich, St Louis, MO, USA). The culture medium used for oocyte maturation was TCM-199 (Gibco-BRL, Grand Island, NY, USA) supplemented with 5% (v/v) fetal bovine serum (FBS; HyClone, Logan, UT, USA), 0.2 mM sodium pyruvate, 5 μg/ml gentamicin sulfate (Sigma-Aldrich) and 20 mAU/ml follicle-stimulating hormone (Denka Pharmaceutical, Kawasaki, Japan). COCs were transferred into 500 μl of the culture medium covered with mineral oil in 4-well dishes (Nunc, Roskilde, Denmark) and cultured at 38.5 C in a humid atmosphere containing 5% CO 2 in air for the time periods mentioned below (Experimental design). At the end of maturation culture, COCs were mechanically denuded of cumulus cells using a small-bore pipette with the help of hyaluronidase (Sigma-Aldrich).
Chemical manipulation of oocyte maturation
Milrinone (Sigma-Aldrich) was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 50 mM, aliquoted and stored at −30 C until use. Irrespective of the final concentration of milrinone (0, 50 or 100 μM), the medium contained 0.2% DMSO. The concentrations of milrinone were chosen according to previous reports [4, 16] .
Delayed oocyte maturation after milrinone treatment has been observed in previous studies [3, 4] as well as in preliminary experiments of the present study. There was a concern that the gaps in the time required for maturation between the experimental groups might lead to varying degrees of oocyte aging, leading to difficulty in accurate comparison at the later events. The delay has been suggested to occur as early as germinal vesicle breakdown (GVBD) [4] . Thus, in the latter series of experiments, butyrolactone I (BL-I; Biomol, Plymouth Meeting, PA, USA)-a specific inhibitor of cyclin-dependent kinases-was used to induce a temporal inhibition of meiotic resumption [17] [18] [19] for the first 18 h of culture. BL-I has been shown to inhibit GVBD for 24 h without impairing the developmental competence of oocytes [20] . BL-I was dissolved in DMSO (20 mM), aliquoted and stored at −30 C until use. Milrinone was not supplemented in the medium during inhibition with BL-I. At the end of BL-I treatment, COCs were washed five times with fresh medium to remove the BL-I and cultured for 20 h before enucleation.
Examination of the timing of first polar body extrusion
Milrinone has been shown to delay the meiotic progression of bovine oocytes by at least 2 h [4] . Thus, first the timing of the first polar body extrusion was examined to determine the approximate timing of oocytes reaching the metaphase II stage in our system. After culturing COCs with or without 100 μM milrinone, the percentage of oocytes showing first polar body extrusion was determined using an inverted microscope (Olympus, Tokyo, Japan) every hour from 20 h to 26 h after the beginning of culture. In both the control and milrinone-treated groups, all COCs were denuded of cumulus cells at 20 h, and these denuded oocytes were returned to the medium for examination. In a series of experiments involving BL-I treatment, extrusion of the first polar body was examined between 15 h and 21 h after the removal of BL-I.
Preparation of donor cells
Cumulus cells obtained from COCs after in vitro maturation were used as the source of the donor cells. After COCs were treated with hyaluronidase, the culture medium containing the cumulus cells was decanted into microtubes and centrifuged at 366× g for 5 min. The resulting cell pellet was washed twice by centrifugation in TCM-199 supplemented with 10% (v/v) FBS and 5 µg/ml gentamicin sulfate and cultured in 4-well culture plates in 500 μl of the same medium. After the cells reached confluence, they were treated with trypsin-EDTA for up to 4 min, washed twice by centrifugation in PBS with 10% (v/v) FBS and then with PBS with 0.5% FBS and used as donor cells. Alternatively, the washed cumulus cells were stored at −80 C using a cell cryopreservation solution (Cellbanker; ZENOAQ, Koriyama, Japan).
Nuclear transfer and activation
The oocytes showing first polar body extrusion were enucleated according to a previously described method [21] . Briefly, a portion of the cytoplasm (10-20%) beneath the first polar body was aspirated from the oocytes treated with 5 μg/ml cytochalasin B (Sigma-Aldrich) using a 30-µm-bore micropipette. To confirm enucleation, the aspirated portion was stained with 10 µg/ml Hoechst 33342 (Roche, Indianapolis, IN, USA) and visualized under UV light (Olympus). When a set of chromosomes was observed in the removed portion, its counterpart (oocyte cytoplasm) was considered to be enucleated.
A donor cell was transferred to the perivitelline space of an enucleated oocyte. A donor-recipient couple was sandwiched between the pair of electrodes (Unique Medical Imada, Sendai, Japan) in Zimmermann cell fusion medium. To each couple, a single direct current pulse of 30 V was applied for 10 μsec using an LF101 fusion machine (Nepa Gene, Chiba, Japan) and washed with TCM-199 containing 10% FBS. The fusion of the reconstructed couples was examined 1 h after the cell fusion treatment. The fused cells were transferred into 50 μl microdrops of modified TCM-199 supplemented with 10 μg/ml cycloheximide and 5 μg/ml cytochalasin B for 5 h at 38.5 C in a humid atmosphere containing 5% CO 2 , 5% O 2 and 90% N 2 .
Embryo culture
Following the cycloheximide treatment, the fused embryos were transferred to a 6-well culture plate containing 50 μl of a serum-free medium (IVD101, Research Institute for the Functional Peptides, Yamagata, Japan) covered with mineral oil and then cultured at 38.5 C in a humid atmosphere containing 5% CO 2 , 5% O 2 and 90% N 2 .
The day of embryo construction was designated as day 0. Cleavage of the embryos was examined on day 3. Cultures were fed on day 4 by removing half of the medium and adding the same amount of fresh medium. Development to the blastocyst stage was examined on day 8.
Examination of the relative location of the first polar body and metaphase plate from the oocyte center
After in vitro maturation, the oocytes showing first polar body extrusion were treated with 2.5 µg/ml cytochalasin B for 15 min and 0.1 mg/ml Hoechst 33342 for 10 min. These oocytes were held in place by a holding pipette, and the first polar body was placed at the three o'clock position. The chromosomes were visualized by UV illumination, and the location of the metaphase plate relative to the first polar body was determined. The angle made at the oocyte center by the two lines that ran toward the centers of the chromosomes/ metaphase plate and the first polar body was examined. The oocytes were carefully rotated until the angle was greatest. At least three candidate images were recorded for each oocyte, and the image showing the greatest angle was used for the data analysis. These oocytes were classified according to whether the angle was 0-30° or exceeded 30° [15] .
Immunofluorescence staining of microtubules and microfilaments of metaphase II stage oocytes
The denuded oocytes were fixed in a microtubule stabilization buffer as described by Ju et al. [22] . These oocytes were first incubated with an anti-α-tubulin primary antibody (1:100, Sigma-Aldrich), consecutively incubated with an Alexa Fluor 488-conjugated antitubulin monoclonal secondary antibody (1:2000; Molecular Probes, Eugene, OR, USA) and 1 IU/ml rhodamine phalloidin (Molecular Probes) and mounted onto glass slides with 10 µg/ml Hoechst 33342. The normality of the chromosome alignment and meiotic spindles was evaluated by epifluorescent microscopy (Eclipse E-600, Nikon, Tokyo, Japan) at 365 nm and 450-490 nm excitation wavelengths, respectively. In addition, the morphology of the chromosomes, microtubules and microfilaments was also evaluated using a confocal laser scanning microscope (D-eclipse C1, Nikon) equipped with an argon-krypton-helium/neon ion laser with 408/488/543 nm excitation barrier filter combinations, respectively, according to the method described by Somfai et al. [23] .
Experimental design
Experiment 1: The effects of milrinone (0, 50 or 100 µM) on the extrusion of the first polar body and the success rate of enucleation were examined after 19 h of COC culture. In another set of experiments, COCs were cultured with or without 100 µM milrinone to compare the kinetics of the first polar body extrusion between 20 h and 26 h after the beginning of culture.
Experiment 2: COCs were cultured for 18 h in medium supplemented with 100 µM BL-I for the temporary arrest of meiosis and then cultured with or without 100 µM milrinone to compare the kinetics of the first polar body extrusion every hour starting 15 h after the removal of BL-I (33 h after the initial isolation of COCs). In another set of experiments, the effects of milrinone (0 or 100 µM) on the extrusion of the polar body and the enucleation efficiency were examined at 20 h after the removal of BL-I. Experiment 3: COCs were treated with 100 µM BL-I for 18 h and then allowed to mature in medium either supplemented with or without 100 µM milrinone to compare the developmental competence after nuclear transfer. Experiment 4: Following arrest for 18 h with BL-I, the effect of 100 µM milrinone on the relative location of the first polar body and metaphase plate from the oocyte center was examined.
Experiment 5: COCs were cultured for 22 h in medium supplemented with or without 100 µM milrinone, either immediately after isolation from the ovary or following arrest for 18 h with BL-I, to examine the spindle morphology and microfilament organization in matured oocytes.
Data presentation and statistical analysis
Unless specified, data are shown as mean percentages of a minimum of three independent experimental replicates with the standard deviation of the mean. Statistical analysis was performed after arcsine transformation of the percentage data. The Student's t-test was used for between-group comparison, and Tukey's test was used for multiple comparisons. Differences were considered significant at P<0.05.
Results
Effects of milrinone treatment on meiotic progression and enucleation
First polar body extrusion was examined 19 h after the beginning of culture, and the oocytes with one polar body were subjected to enucleation. As shown in Table 1 , while milrinone-treated oocytes tended to have a lower polar body extrusion rate than control oocytes, 100 µM milrinone improved the enucleation rate, compensating for the decreased polar body extrusion. No difference was observed in the overall enucleation rates among the groups based on the number of cultured COCs; the percentages of enucleation after maturation in the medium supplemented with 0-, 50-and 100-µM milrinone were 42.2 ± 15.1, 39.4 ± 15.4 and 45.2 ± 13.5%, respectively (P>0.05).
As shown in Fig. 1A , when the kinetics of the first polar body extrusion was compared between oocytes maturing in medium supplemented with or without 100 µM milrinone, a higher percentage of the extrusion was observed in the control medium than milrinonesupplemented medium at 20 and 22 h (20 h, 72.0 ± 4.5 vs. 48.5 ± 4.5%, P<0.01; 22 h, 80.3 ± 2.7 vs. 61.2 ± 8.9%, P<0.05, respectively). However, after 23 h, there was no statistically-significant difference in the timing or frequency of the first polar body extrusion between the groups (Fig. 1A) , suggesting that there was about a 2-h delay in the kinetics of nuclear maturation in milrinone-treated oocytes.
Milrinone treatment after meiotic inhibition by BL-I
Eighteen hours of preliminary BL-I treatment decreased the difference in the kinetics of polar body extrusion between milrinone-treated oocytes and controls (Fig. 1B) . When 43 control oocytes and 46 milrinone-treated oocytes were fixed 21 h after the removal of BL-I, approximately 80% had reached metaphase II in both the groups. This two-step oocyte maturation system provided us with relatively homologous oocyte populations in terms of the rate and timing of the progression to the metaphase II stage, thereby allowing examination of enucleation rate and developmental competence of oocytes (Fig. 1B ). As shown in Table 2 , a higher enucleation rate was observed in the milrinone-treated group than in the control, confirming the results of the experiments without using BL-I as described above. Moreover, the enucleation rate was significantly improved based on the number of COCs as a result of the similar maturation rates between the experimental groups.
In addition, milrinone treatment significantly improved the percentage of embryos that developed to the blastocyst stage after fusion (P=0.020, Table 3 ). When the percentage calculation was based on the number of COCs, the improvement was more significant (P=0.010, Table 3 ), owing to the combination of enucleation rate and developmental competence.
Relative location of the first polar body and metaphase plate
As shown in Table 4 , when the angle made by the metaphase plate, oocyte center and first polar body was examined (Fig. 2) , the percentage of oocytes exhibiting 0-30° angles was significantly higher in the milrinone-treated group than in the control group (80.5 ± 12.2 vs. 58.7 ± 14.3%, P<0.05). Accordingly, a significantly larger proportion of oocytes exhibited an angle exceeding 30° in the control group than that in the milrinone-treated group.
Spindle morphology and microfilament organization of metaphase II oocytes
Further examinations were conducted by visualizing chromosomes, microtubules and microfilaments of oocytes mounted on glass slides (Fig. 3) . The majority of oocytes (73.7-79.8%, Table 5 ) exhibited normal morphology of the spindle and cortical microfilaments (Fig. 3A, A*) ; no significant differences were observed among the groups (P>0.05). Spindle abnormalities, observed in all groups with low frequency, included disassembled microtubules, dispersed chromosomes (Fig. 3B, B*) and absence of the spindle. On the other hand, the presence of small actin clusters was the typical abnormality of the cortical microfilaments (Fig. 3C, C*) .
Discussion
When bovine oocytes were matured in milrinone-supplemented medium, beneficial effects were observed in the following two characteristics-successful enucleation rate and developmental competence of the resulting embryos. These benefits additively improved the yield of nuclear transfer embryos achieving development to the blastocyst stage. However, milrinone also delayed the timing of polar body extrusion by at least 2 h, without impairing the oocyte ability. To decrease the time lag between the experimental groups, a temporal meiotic inhibition was induced using BL-I. It has been shown that BL-I treatment itself benefits oocyte maturation [18] . Although BL-I was used in the present study to equalize the conditions for examination of the effects of milrinone treatment, it is possible that BL-I treatment also enhanced oocyte competence to undergo embryo development.
The involvement of cAMP in various regulatory aspects of oocyte maturation has been extensively studied [24] . Given that cAMP levels in oocytes and cumulus cells in vivo are transiently elevated after an LH surge [25] , treatments that elevate cAMP levels may mimic proper signal pathways in oocytes. Cellular cAMP levels in vitro can be elevated by the following three methods: (1) the inhibition of cAMP degradation by using phosphodiesterase inhibitors, as performed in the present study, (2) the stimulation of cAMP synthesis by using adenylate cyclase-stimulating reagents [16] or invasive adenylate cyclase [26, 27] and (3) using cell-permeable cAMP analogs, but not cAMP itself [28] . Essentially, all these approaches can result in some type of improvement in oocyte competence. The effective dose of milrinone as found in the present study was 100 µM, which Before taking photographs, oocytes were slightly rotated to find a position that would make the angle greatest, and at least three candidate photographs were taken. The angle indicated by the arrow (in B) was measured, and the largest among the same group was used for data analysis. was consistent with that reported by a previous study [4] . Doses exceeding 100 µM have been avoided because of a concern over the accompanying deleterious effects of DMSO used as the solvent. Unlike developmental competence, which is the intrinsic value of embryos, enucleation of oocytes is involved only in nuclear transfer embryo production. However, various enucleation methods have been reported, including chemical treatment [10, [29] [30] [31] [32] and mechanical removal of cytoplasm, as performed in the present study. The fact that attempts have been made to facilitate enucleation indicates the difficulty in the application of this procedure, particularly in cattle. Mechanical removal of a portion of the cytoplasm-presumably along with chromosomes-is a direct and simple method; however, there is a possibility of removing a blank portion if the chromosome location is not accurately determined. The results of the present study showed that milrinone treatment reduced this risk. This observation is consistent with that previously reported for miniature porcine oocytes treated with dbcAMP [15] . Successful enucleation after dbcAMP treatment was suggested to be attributable to synchronized polar body extrusion and an increased proportion of oocytes having the metaphase plate adjacent to the first polar body at the time of enucleation [15] . A similar observation was made in the present study with bovine oocytes in terms of the relative location of the first polar body and metaphase plate.
A group of oocytes extruding the first polar body earlier than other oocytes, as observed in control oocytes in Fig. 1A , generates a concern that such oocytes may be also aging earlier than others. Oocyte aging has been known to increase the distance between the polar body and spindle [33] . Although aging-related dislocation of the spindle in porcine oocytes was related to the actin cytoskeleton, which is responsible for anchoring the spindle to the oocyte cortical area [34] , no major cytoskeletal element alterations were observed in milrinone treated bovine oocytes (Table 5 ). These results suggest that microfilament degradation may not be the major cause of the increased distance found between the metaphase plate and polar body in the control oocytes in the present study. In fact, it has been suggested that aging causes less damage in cortical microfilaments in bovine oocytes in comparison to porcine oocytes [23] . It seems probable that some factors other than the timing of maturation and cytoskeletal aging might be involved in the improved enucleation rate after the milrinone treatment. For example, cAMP can facilitate cytoplasmic maturation through improving gap junctional communication during in vitro maturation, which is associated with the regulation of important kinases [35] .
In conclusion, the observations in the present study provided insights in terms of enucleation rate and developmental competence of oocytes. These observations should further encourage studies based on modulations of cAMP levels in oocytes during in vitro maturation.
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